Literature DB >> 16479469

[Disseminated herpes zoster in diabetes mellitus].

N Graue1, S Grabbe, J Dissemond.   

Abstract

HISTORY AND ADMISSION
FINDINGS: A 71-year old man presented with painful hemorrhagic vesicles and papules over the entire body that had persisted for three days. Type 2 diabetes mellitus type 2 had been diagnosed 20 years ago and had not been treated for the last 5 years. Therapy had been discontinued by the patient. INVESTIGATIONS: HbA1c (11,9%) and blood glucose levels (up to 360 mg/dl) were abnormal. Varicella-zoster-DNA was replicated by PCR from the vesicle fluid. DIAGNOSIS AND TREATMENT: After the clinical diagnosis of disseminated herpes zoster had been confirmed systemic therapy with aciclovir 10 mg/kg day was started. There was no evidence of malignancy. Insulin therapy was initiated.
CONCLUSION: Dissemination is a rare complication of herpes zoster, aided by immunosuppression. In the presented case there was no evidence of malignancy or other cause of immunosuppression, but the patient also had type 2 diabetes with very high blood glucose levels. The diabetes was thought to be causally related to the ineffective immune response to varicella zoster virus. There has been no previous published report of this relationship.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479469     DOI: 10.1055/s-2006-932529

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  5 in total

1.  Disseminated Cutaneous Herpes Zoster in a Patient with Uncontrolled Diabetes Mellitus.

Authors:  Shashikant Malkud; Santosh M Patil
Journal:  J Clin Diagn Res       Date:  2015-07-01

2.  Disseminated zoster in an elderly patient.

Authors:  J Capron; O Steichen
Journal:  Infection       Date:  2009-04       Impact factor: 3.553

3.  Visceral disseminated varicella zoster infection: a rare cause of acute abdomen in a patient with well-controlled diabetes mellitus-a case report.

Authors:  Daisuke Mizu; Haruka Nishida; Yoshinori Matsuoka; Koichi Ariyoshi
Journal:  BMC Infect Dis       Date:  2022-03-03       Impact factor: 3.090

4.  Four cases of hemorrhagic herpes zoster associated with dabigatran therapy.

Authors:  Stefano Veraldi; Andrea E Beretta; Cristina Beatrice Spigariolo
Journal:  Dermatol Ther       Date:  2022-03-13       Impact factor: 3.858

5.  IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.

Authors:  G N Malavige; L T Rohanachandra; L Jones; L Crack; M Perera; N Fernando; D Guruge; G S Ogg
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.